3543 results for «2184»

Filter By

3543 results

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

Management of paravalvular leak

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...

Management of paravalvular leak

TAVI and coronary artery disease

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the complex interplay between TAVI and coronary artery disease in this comprehensive session. Explore the decision-making process for optimal sequencing of PCI and TAVI, and examine cases of acute myocardial infarction due to coronary embolism and delayed coronary obstruction following TAVI. Gain insights into...

TAVI and coronary artery disease

Redo mitral procedures

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to gain insights into the management of recurrent mitral regurgitation after percutaneous mitral valve interventions. Discover various redo procedures, including the use of the PASCAL system for recurrent MR after MitraClip, redo M-TEER for torn posterior leaflet, and successful redo TEER and MitraClip...

Redo mitral procedures

TAV-in-TAV cases

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to delve into the complexities and challenges of TAV-in-TAV procedures. Gain insights into various case studies, including a successful TAV-in-TAV with coronary protection, a case of CABG and TAV-in-TAV, TAVI in a patient with failed homograft and three previous sternotomies, and concurrent mitral...

TAV-in-TAV cases

Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...

Imaging strategies for optimal valve selection and outcomes in TAVI

Mastering mitral valve disease: diagnosis, management, and intervention

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

Mastering mitral valve disease: diagnosis, management, and intervention

Advancing imaging and intervention strategies for mitral valve disease

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Explore the latest imaging techniques for transcatheter mitral valve interventions, including patient screening, device selection, and strategies for challenging anatomies. Gain insights into TEER and transcatheter mitral valve replacement to optimize patient outcomes.

Advancing imaging and intervention strategies for mitral valve disease

Advancing the management of tricuspid valve disease: diagnosis, imaging, and intervention

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores tricuspid valve disease, focusing on the determinants and severity of tricuspid regurgitation, right heart assessment, and available treatment options. Through case studies and expert discussions, learn about imaging techniques, the heart team approach, and best practices for selecting patients for transcatheter tricuspid valve...

Advancing the management of tricuspid valve disease

Advancing transcatheter solutions for tricuspid valve disease

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...

Advancing transcatheter solutions for tricuspid valve disease

Optimizing diagnosis and treatment in multivalvular heart disease

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.

Optimizing diagnosis and treatment in multivalvular heart disease

Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...

Navigating complexities in multivalvular heart disease

Aortic valve disease - Aortic stenosis management: Diagnosis, classification & treatment strategies

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

This comprehensive session explores the latest advancements in classifying and managing aortic stenosis. Learn key techniques for assessing severity, even in complex cases, and gain insights into evaluating asymptomatic patients with severe disease. Discover multi-modality imaging approaches for diagnosing and treating bicuspid aortic valve, along with...

Aortic stenosis management: Diagnosis, classification & treatment strategies

Taking the next step in the evolution of aortic regurgitation treatment

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Explore the latest in aortic regurgitation treatment, including a TAVI case with the Trilogy device, imaging challenges, and future advancements like CMR and guideline updates.

Taking the next step in the evolution of aortic regurgitation treatment

TAVI in bicuspid anatomy

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the key insights from this PCR Tokyo Valves 2025 session focused on TAVI in bicuspid anatomy. Learn why TAVI for bicuspid aortic stenosis (AS) shows comparable long-term outcomes to tricuspid AS in registry data, and understand the importance of patient selection, precise valve sizing, and...

TAVI in bicuspid anatomy

M-TEER for primary mitral regurgitation

08 Feb 2025 – From PCR Tokyo Valves 2025

In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...

M-TEER for primary mitral regurgitation

M-TEER around the world

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...

M-TEER around the world

High-risk TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...

High-risk TAVI

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

Standardised implant technique with self-expandable valve

08 Feb 2025 – From PCR Tokyo Valves 2025

Don’t miss this PCR Tokyo Valves 2025 session replay, where leading experts share key techniques for simplifying and optimising TAVI procedures with the Evolut device. This session covers essential insights into safely performing procedures on patients with various anatomical types using the self-expandable valve, while emphasising...

Standardised implant technique with self-expandable valve
Didn’t find what you were looking for?